^
Association details:
| Biomarker: | VEGFA elevation |
|---|---|
| Cancer: | Hepatocellular Cancer |
| Drug: | Sutent (sunitinib) (c-KIT inhibitor, VEGFR inhibitor, PDGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib
Excerpt:
For VEGF-A at baseline, patients with and without disease control had median baseline levels of 108.7 and 46.6 pg/mL, respectively (P = 0.0332) and VEGF-A levels were also significantly elevated in Choi responders (P = 0.0250).
DOI:
10.1186/1479-5876-9-120
